会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 11. 发明申请
    • BENZOCYCLODECANE DERIVATIVES WITH ANTITUMOR ACTIVITY
    • 具有抗肿瘤活性的苯并四氢吡喃衍生物
    • WO2003055861A1
    • 2003-07-10
    • PCT/EP2002/014514
    • 2002-12-18
    • PHARMACIA ITALIA SPAANGIOLINI, MauroDUCKI, SylvieMENICHINCHERI, MariaMONGELLI, NicolaVANOTTI, ErmesCIOMEI, Marina
    • ANGIOLINI, MauroDUCKI, SylvieMENICHINCHERI, MariaMONGELLI, NicolaVANOTTI, ErmesCIOMEI, Marina
    • C07D233/54
    • C07D233/64C07C45/673C07C49/747C07C67/08C07C67/29C07C67/293C07C69/007C07C69/013C07C69/618C07C2602/12C07D213/56C07D263/32C07D277/30C07H15/203C07C69/16
    • A compound which is a benzocyclodecane of the formula I wherein: ----- at positions 8-9 and 11-12 independently represents a single or double bond, -R1 is =O, or -OR7, R7 is H, C1-C7 alkanoyl, benzoyl, C1-C10 alkyl, C2-C10 alkenyl or COCH=CHR8, R8 is aryl or heterocyclyl;-R2 and -R3 are H, =O or -OR9, R9 is H, C1-C7 alkanoyl or benzoyl; when at position 11-12 there is a single bond, then -R4 represents=O, =CH2, =CHCOOR10, R10 is C1-C10 alkyl or aryl; =CH(OCH3), -OR9; -CH2OR11, R11 is H or a sugar residue, -COR12 , R12 is H, -OH or -OR10; or when at position 11-12 there is a double bond, then -R4 is -CH2OR11 or -COR12; - R5 and -R6 are H or, when at position 8-9 there is a single bond, taken together form a cyclopropane ring; R13 is H or 1-3 substituents selected from C1-C6 alkyl, C2-C6 alkenyl, phenyl, phenyl C1-C6 alkyl, halogen, hydroxy, C1-C6 alkoxy, aryloxy, cyano, nitro, amino, C1-C10 alkylamino, arylamino, C1-C7 alkanoylamino, aroylamino, hydroxycarbonyl, aminocarbonyl, C1-C6 alkylcarbonyl, C1-C6 alkylaminosulfonyl and arylaminosulfonyl group; with the provisos that if R1 and R4 =O, then one of R2, R3, R5, R6 and R13 is not H atom; or a pharmaceutically acceptable salt thereof. These benzocyclodecane derivatives are endowed with antitumor activity; a process and new intermediates for their preparation, the pharmaceutical compositions containing them, and their use in the prevention, control and treatment of cancer are also provided.
    • 作为式I的苯并环十一烷的化合物,其中: - 在8-9和11-12位,独立地表示单键或双键,-R1为=或-OR7,R7为H,C1- C7烷酰基,苯甲酰基,C1-C10烷基,C2-C10烯基或COCH = CHR8,R8是芳基或杂环基; -R2和-R3是H,= O或-OR9,R9是H,C1-C7烷酰基或苯甲酰基; 当在11-12位存在单键时,则-R 4表示= O,= CH 2,= CHCOOR 10,R 10是C 1 -C 10烷基或芳基; = CH(OCH 3),-OR 9; -CH 2 OR 11,R 11为H或糖残基,-COR 12,R 12为H,-OH或-OR 10; 或者当在11-12位存在双键时,则-R 4是-CH 2 OR 11或-COR 12; -R 5和-R 6是H或当在8-9位存在单键时,一起形成环丙烷环; R 13是H或1-3个选自C 1 -C 6烷基,C 2 -C 6烯基,苯基,苯基C 1 -C 6烷基,卤素,羟基,C 1 -C 6烷氧基,芳氧基,氰基,硝基,氨基,C 1 -C 10烷基氨基, 芳基氨基,C 1 -C 7烷酰基氨基,芳酰氨基,羟基羰基,氨基羰基,C 1 -C 6烷基羰基,C 1 -C 6烷基氨基磺酰基和芳基氨基磺酰基; 条件是如果R1和R4 = O,则R2,R3,R5,R6和R13之一不是H原子; 或其药学上可接受的盐。 这些苯并环十一烷衍生物具有抗肿瘤活性; 还提供了其制备方法和新的中间体,含有它们的药物组合物及其在预防,控制和治疗癌症中的用途。